A meta-analysis of leucine-rich repeat kinase 2 (LRRK2) polymorphisms in Alzheimer’s disease

Pathogenesis and the development of Alzheimer’s disease (AD) are subject to several environmental and genetic factors. This study was aimed to estimate the frequency of mutations in leucine-rich repeat kinase 2 (LRRK2) gene to examine the association between these mutations and risk of AD. For findi...

Full description

Bibliographic Details
Main Authors: Reza Fatahian, Seyed Reza Bagheri, Masoud Sadeghi
Format: Article
Language:English
Published: Termedia Publishing House 2019-03-01
Series:Folia Neuropathologica
Subjects:
Online Access:https://www.termedia.pl/A-meta-analysis-of-leucine-rich-repeat-kinase-2-LRRK2-polymorphisms-in-Alzheimer-s-disease,20,36139,1,1.html
_version_ 1818315845101682688
author Reza Fatahian
Seyed Reza Bagheri
Masoud Sadeghi
author_facet Reza Fatahian
Seyed Reza Bagheri
Masoud Sadeghi
author_sort Reza Fatahian
collection DOAJ
description Pathogenesis and the development of Alzheimer’s disease (AD) are subject to several environmental and genetic factors. This study was aimed to estimate the frequency of mutations in leucine-rich repeat kinase 2 (LRRK2) gene to examine the association between these mutations and risk of AD. For finding the articles, four databases including PubMed, Web of Science, Scopus, and Cochrane Library were checked up to August 2018. An analysis was done by RevMan 5.3 using crude odds ratio (OR) and 95% confidence intervals (CIs) to determine the association between LRRK2 polymorphisms and the risk of AD. Of 359 articles identified in the databases, 13 studies were included and analysed in the meta-analysis. There was no significant risk of AD related to five LRRK2 polymorphisms (rs33949390, rs34778348, rs7308720, rs34637584, and rs35870237). The results showed that LRRK2 variants (p.R1628P, p.G2385R, p.N551K, p.G2019S, and p.I2020T) were not associated with the risk of AD and were not a common cause of AD in populations. Nevertheless, p.R1628P can be examined in patients with AD in other populations in the future studies.
first_indexed 2024-12-13T09:12:00Z
format Article
id doaj.art-bd6f33082141429891b0692eb88de363
institution Directory Open Access Journal
issn 1641-4640
1509-572X
language English
last_indexed 2024-12-13T09:12:00Z
publishDate 2019-03-01
publisher Termedia Publishing House
record_format Article
series Folia Neuropathologica
spelling doaj.art-bd6f33082141429891b0692eb88de3632022-12-21T23:52:54ZengTermedia Publishing HouseFolia Neuropathologica1641-46401509-572X2019-03-015711510.5114/fn.2019.8382536139A meta-analysis of leucine-rich repeat kinase 2 (LRRK2) polymorphisms in Alzheimer’s diseaseReza FatahianSeyed Reza BagheriMasoud SadeghiPathogenesis and the development of Alzheimer’s disease (AD) are subject to several environmental and genetic factors. This study was aimed to estimate the frequency of mutations in leucine-rich repeat kinase 2 (LRRK2) gene to examine the association between these mutations and risk of AD. For finding the articles, four databases including PubMed, Web of Science, Scopus, and Cochrane Library were checked up to August 2018. An analysis was done by RevMan 5.3 using crude odds ratio (OR) and 95% confidence intervals (CIs) to determine the association between LRRK2 polymorphisms and the risk of AD. Of 359 articles identified in the databases, 13 studies were included and analysed in the meta-analysis. There was no significant risk of AD related to five LRRK2 polymorphisms (rs33949390, rs34778348, rs7308720, rs34637584, and rs35870237). The results showed that LRRK2 variants (p.R1628P, p.G2385R, p.N551K, p.G2019S, and p.I2020T) were not associated with the risk of AD and were not a common cause of AD in populations. Nevertheless, p.R1628P can be examined in patients with AD in other populations in the future studies.https://www.termedia.pl/A-meta-analysis-of-leucine-rich-repeat-kinase-2-LRRK2-polymorphisms-in-Alzheimer-s-disease,20,36139,1,1.htmlalzheimer’s disease lrrk2 variants polymorphism meta-analysis
spellingShingle Reza Fatahian
Seyed Reza Bagheri
Masoud Sadeghi
A meta-analysis of leucine-rich repeat kinase 2 (LRRK2) polymorphisms in Alzheimer’s disease
Folia Neuropathologica
alzheimer’s disease
lrrk2
variants
polymorphism
meta-analysis
title A meta-analysis of leucine-rich repeat kinase 2 (LRRK2) polymorphisms in Alzheimer’s disease
title_full A meta-analysis of leucine-rich repeat kinase 2 (LRRK2) polymorphisms in Alzheimer’s disease
title_fullStr A meta-analysis of leucine-rich repeat kinase 2 (LRRK2) polymorphisms in Alzheimer’s disease
title_full_unstemmed A meta-analysis of leucine-rich repeat kinase 2 (LRRK2) polymorphisms in Alzheimer’s disease
title_short A meta-analysis of leucine-rich repeat kinase 2 (LRRK2) polymorphisms in Alzheimer’s disease
title_sort a meta analysis of leucine rich repeat kinase 2 lrrk2 polymorphisms in alzheimer s disease
topic alzheimer’s disease
lrrk2
variants
polymorphism
meta-analysis
url https://www.termedia.pl/A-meta-analysis-of-leucine-rich-repeat-kinase-2-LRRK2-polymorphisms-in-Alzheimer-s-disease,20,36139,1,1.html
work_keys_str_mv AT rezafatahian ametaanalysisofleucinerichrepeatkinase2lrrk2polymorphismsinalzheimersdisease
AT seyedrezabagheri ametaanalysisofleucinerichrepeatkinase2lrrk2polymorphismsinalzheimersdisease
AT masoudsadeghi ametaanalysisofleucinerichrepeatkinase2lrrk2polymorphismsinalzheimersdisease